Enveric Biosciences (NASDAQ: ENVB) agreed to license one of its experimental psychedelic drug candidates to MycoMedica Life Sciences in a deal worth as much as $62 million, as the biotech company keeps its eye on its non-hallucinogenic treatments. The agreement grants MycoMedica exclusive global rights to EB-002, a synthetic prodrug …
43% – How much the AdvisorShares Pure US Cannabis ETF declined in the past week Cannabis investors had high hopes for the election last Tuesday, with strong optimism that Florida would join the ranks of adult-use cannabis states. While a majority of voters approved the measure, Amendment 3 ultimately fell …
CBD products were once buzzworthy in the hemp industry, but their lack of buzz has convenience stores and smoke shops shifting gears toward intoxicating hemp products, according to data from Management Science Associates. MSA surveyed roughly 50 distributors and 15 of the top 21 wholesalers with information through October 2023. …
The Daily Hit is a recap of the top financial news stories for Monday, November 11, 2024. On the Site Former Surterra Wellness executives sue Wrigley over overvalued stock payments The employees are facing huge tax bills on the inflated shares, but the shares are worthless Read more here. DC …